Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Board Changes

24 May 2017 07:00

RNS Number : 0354G
Softcat PLC
24 May 2017
 

24 May 2017

 

 

Softcat plc

 

("Softcat", the "Company")

 

Board Changes

 

The Board of Softcat announces that Martin Hellawell has decided to step down as Chief Executive Officer once a successor is in place. At that time, and given Martin's extensive and unparalleled experience in the sector, the Board intends to appoint him to take over as Non-Executive Chairman and Martin has agreed to do so. Brian Wallace, currently the Non-Executive Chairman, would then retire from the Board. A search for the new Chief Executive Officer will be led by Brian Wallace and Lee Ginsberg, Senior Independent Director.

 

The decision to appoint Martin as Non-Executive Chairman has been discussed with a number of the Company's largest shareholders and reflects the Board's strong view that, in addition to the leadership role Martin has played in driving the business forward, he also enjoys an outstanding reputation in the sector and has well developed relationships built over many years and it is in the interest of the Company and its shareholders to continue to benefit from these attributes going forward.

 

Commenting on his decision, Martin Hellawell said: "It has been a great pleasure for me to have led Softcat for the past 11 years. It has been an intense period and it is my sincere belief that it is now the right time to step down and for the Board to appoint a new leader to the business, one with fresh energy and approaches to capitalise on the fantastic opportunities ahead of us.

 

The business is in robust shape and we have great people, a unique business and a highly motivated corporate culture that celebrates success and drives our growth. We reported a strong first half earlier this year and have confirmed this morning that the business continued to trade well in the third quarter.

 

I am delighted that the intention is for me to continue being part of the organisation in the role of Non-Executive Chairman. I look forward to the new role and challenge and will support the new Chief Executive Officer and the business in every way I can.

 

In the meantime, we have a job of work to do and I remain fully focussed on leading Softcat as Chief Executive Officer until my successor is in place."

 

Brian Wallace, Non-Executive Chairman said: "It has been a privilege for me to have been on the Board of this hugely positive, vibrant and successful Company since 2013. Following Martin's decision to step down as Chief Executive Officer, and having chaired the company through its highly successful IPO and first two years as a PLC, I strongly believe that the appointment in due course of Martin Hellawell as Non-Executive Chairman is in the best interests of the Company, its employees, shareholders and other stakeholders."

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of Softcat is Win Chime, Company Secretary.

 

 

For further information please contact:

 

Softcat plc

Brian Wallace, Non-Executive Chairman

Lee Ginsberg, Senior Independent Director

Martin Hellawell, Chief Executive Officer

 

Tel: + 44(0) 1628 403 403

Media Enquiries - FTI Consulting LLP

Ed Bridges

Matt Dixon

Dwight Burden

Tel: + 44(0) 203 727 1000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFFAEAIVFID
Date   Source Headline
8th Jan 20252:02 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:52 amRNSTotal Voting Rights
12th Dec 20243:07 pmRNSDirector/PDMR Shareholding
10th Dec 20243:40 pmRNSDirector/PDMR Shareholding
10th Dec 202412:54 pmRNSResult of AGM
4th Dec 20242:22 pmRNSDirector/PDMR Shareholding
2nd Dec 202412:11 pmRNSTotal Voting Rights
26th Nov 202410:47 amRNSDirector/PDMR Shareholding
26th Nov 202410:45 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSQ1 2025 Trading Update
18th Nov 20241:55 pmRNSBlock listing Interim Review
11th Nov 20243:31 pmRNSDirector/PDMR Shareholding
1st Nov 20242:36 pmRNSAnnual Financial Report
1st Nov 20249:19 amRNSTotal Voting Rights
24th Oct 20247:00 amRNSFinal Results
14th Oct 202410:01 amRNSHolding(s) in Company
8th Oct 20243:06 pmRNSDirector/PDMR Shareholding
7th Oct 20242:28 pmRNSNotice of Results
1st Oct 20242:37 pmRNSTotal Voting Rights
26th Sep 20249:34 amRNSHolding(s) in Company
16th Sep 20249:41 amRNSHolding(s) in Company
13th Sep 202410:21 amRNSHolding(s) in Company
11th Sep 20249:26 amRNSDirector/PDMR Shareholding
22nd Aug 20249:30 amRNSHolding(s) in Company
9th Aug 202410:45 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSTotal Voting Rights
24th Jul 20249:32 amRNSHolding(s) in Company
9th Jul 202412:29 pmRNSDirector/PDMR Shareholding
1st Jul 20249:17 amRNSTotal Voting Rights
10th Jun 202412:53 pmRNSChange of Adviser
10th Jun 202411:24 amRNSDirector/PDMR Shareholding
3rd Jun 20249:26 amRNSTotal Voting Rights
28th May 20247:00 amRNSQ3 2024 Trading Update
23rd May 202410:02 amRNSBlock listing Interim Review
10th May 20242:25 pmRNSDirector/PDMR Shareholding
9th May 20243:09 pmRNSDirector/PDMR Shareholding
1st May 202410:50 amRNSTotal Voting Rights
9th Apr 20249:45 amRNSDirector/PDMR Shareholding
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20241:00 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSHalf-year Report
15th Mar 20242:45 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSNotice of Results
1st Mar 20242:28 pmRNSHolding(s) in Company
1st Mar 202410:47 amRNSTotal Voting Rights
8th Feb 20249:34 amRNSDirector/PDMR Shareholding
1st Feb 20249:49 amRNSTotal Voting Rights
30th Jan 20249:58 amRNSHolding(s) in Company
9th Jan 20243:48 pmRNSDirector/PDMR Shareholding
9th Jan 202412:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.